Literature DB >> 20826676

Enhanced function of prefrontal serotonin 5-HT(2) receptors in a rat model of psychiatric vulnerability.

Madhurima Benekareddy1, Nathalie M Goodfellow, Evelyn K Lambe, Vidita A Vaidya.   

Abstract

Prefrontal serotonin 5-HT(2) receptors have been linked to the pathogenesis and treatment of affective disorders, yet their function in psychiatric vulnerability is not known. Here, we examine the effects of 5-HT(2) receptors in a rat model of psychiatric vulnerability using electrophysiology, gene expression, and behavior. Following the early stress of chronic maternal separation, we found that serotonin has atypical 5-HT(2) receptor-mediated excitatory effects in the adult prefrontal cortex that were blocked by the 5-HT(2A) receptor antagonist MDL 100907. In the absence of a serotonergic agonist, the intrinsic excitability of the prefrontal cortex was not enhanced relative to controls. Yet, in response to stimulation of 5-HT(2) receptors, adult animals with a history of early stress exhibit heightened prefrontal network activity in vitro, enhanced immediate early gene expression in vivo, and potentiated head shake behavior. These changes arise in the absence of any major alteration of prefrontal 5-HT(2A/C) mRNA expression or 5-HT(2) receptor binding. Our microarray results and quantitative PCR validation provide insight into the molecular changes that accompany such enhanced 5-HT(2) receptor function in adult animals following early stress. We observed persistent prefrontal transcriptome changes, with significant enrichment of genes involved in cellular developmental processes, regulation of signal transduction, and G-protein signaling. Specific genes regulated by early stress were validated in an independent cohort, and several altered genes were normalized by chronic blockade of 5-HT(2) receptors in adulthood. Together, our results demonstrate enhanced prefrontal 5-HT(2) receptor function and persistent alterations in prefrontal gene expression in a rat model of psychiatric vulnerability.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20826676      PMCID: PMC4177096          DOI: 10.1523/JNEUROSCI.3245-10.2010

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  75 in total

1.  Developmental regulation of 5-HT2 and 5-HT1c mRNA and receptor levels.

Authors:  B L Roth; M W Hamblin; R D Ciaranello
Journal:  Brain Res Dev Brain Res       Date:  1991-01-15

2.  A preformed complex of postsynaptic proteins is involved in excitatory synapse development.

Authors:  Kimberly Gerrow; Stefano Romorini; Shahin M Nabi; Michael A Colicos; Carlo Sala; Alaa El-Husseini
Journal:  Neuron       Date:  2006-02-16       Impact factor: 17.173

3.  Long-term consequences of neonatal rearing on central corticotropin-releasing factor systems in adult male rat offspring.

Authors:  Paul M Plotsky; K V Thrivikraman; Charles B Nemeroff; Christian Caldji; Shakti Sharma; Michael J Meaney
Journal:  Neuropsychopharmacology       Date:  2005-12       Impact factor: 7.853

4.  Effects of conditioned fear stress on 5-HT release in the rat prefrontal cortex.

Authors:  M Yoshioka; M Matsumoto; H Togashi; H Saito
Journal:  Pharmacol Biochem Behav       Date:  1995 Jun-Jul       Impact factor: 3.533

5.  Brain serotonin2 receptors in major depression: a positron emission tomography study.

Authors:  L N Yatham; P F Liddle; I S Shiah; G Scarrow; R W Lam; M J Adam; A P Zis; T J Ruth
Journal:  Arch Gen Psychiatry       Date:  2000-09

6.  Epigenetic modulation of the developing serotonergic neurotransmission in the semi-precocial rodent Octodon degus.

Authors:  Grzegorz Jezierski; Katharina Braun; Michael Gruss
Journal:  Neurochem Int       Date:  2006-01-19       Impact factor: 3.921

7.  Prefrontal cortical network activity: Opposite effects of psychedelic hallucinogens and D1/D5 dopamine receptor activation.

Authors:  E K Lambe; G K Aghajanian
Journal:  Neuroscience       Date:  2007-02-09       Impact factor: 3.590

8.  Stimulation of the beta3-Adrenoceptor as a novel treatment strategy for anxiety and depressive disorders.

Authors:  Jeanne Stemmelin; Caroline Cohen; Jean-Paul Terranova; Matilde Lopez-Grancha; Philippe Pichat; Olivier Bergis; Michel Decobert; Vincent Santucci; Dominique Françon; Richard Alonso; Stephen M Stahl; Peter Keane; Patrick Avenet; Bernard Scatton; Gérard le Fur; Guy Griebel
Journal:  Neuropsychopharmacology       Date:  2007-04-25       Impact factor: 7.853

9.  Region specific changes in forebrain 5-hydroxytryptamine1A and 5-hydroxytryptamine2A receptors in isolation-reared rats: an in vitro autoradiography study.

Authors:  M A Preece; J W Dalley; D E H Theobald; T W Robbins; G P Reynolds
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

10.  Augmentation of antidepressants with perospirone for treatment-resistant major depressive disorder.

Authors:  Yasushi Sato; Norio Yasui-Furukori; Taku Nakagami; Manabu Saito; Sunao Kaneko
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2009-01-06       Impact factor: 5.067

View more
  33 in total

1.  Irving Page Lecture: 5-HT(2A) serotonin receptor biology: interacting proteins, kinases and paradoxical regulation.

Authors:  Bryan L Roth
Journal:  Neuropharmacology       Date:  2011-02-01       Impact factor: 5.250

2.  Effects of dominance status on conditioned defeat and expression of 5-HT1A and 5-HT2A receptors.

Authors:  Kathleen E Morrison; Cody L Swallows; Matthew A Cooper
Journal:  Physiol Behav       Date:  2011-02-26

3.  Gene-environment interactions in antisocial behavior are mediated by early-life 5-HT2A receptor activation.

Authors:  Sean C Godar; Laura J Mosher; Simona Scheggi; Paola Devoto; Kelly M Moench; Hunter J Strathman; Cori M Jones; Roberto Frau; Miriam Melis; Carla Gambarana; Brent Wilkinson; M Graziella DeMontis; Stephen C Fowler; Marcelo P Coba; Cara L Wellman; Jean C Shih; Marco Bortolato
Journal:  Neuropharmacology       Date:  2019-02-01       Impact factor: 5.250

4.  Sex and exercise interact to alter the expression of anabolic androgenic steroid-induced anxiety-like behaviors in the mouse.

Authors:  Marie M Onakomaiya; Donna M Porter; Joseph G Oberlander; Leslie P Henderson
Journal:  Horm Behav       Date:  2014-04-21       Impact factor: 3.587

5.  Contribution of Hippocampal 5-HT3 Receptors in Hippocampal Autophagy and Extinction of Conditioned Fear Responses after a Single Prolonged Stress Exposure in Rats.

Authors:  Zhong-Min Wu; Li-Hua Yang; Rong Cui; Gui-Lian Ni; Feng-Tian Wu; Yong Liang
Journal:  Cell Mol Neurobiol       Date:  2016-06-21       Impact factor: 5.046

6.  Serotonin (5-HT) 5-HT2A Receptor (5-HT2AR):5-HT2CR Imbalance in Medial Prefrontal Cortex Associates with Motor Impulsivity.

Authors:  Noelle C Anastasio; Sonja J Stutz; Latham H L Fink; Sarah E Swinford-Jackson; Robert M Sears; Ralph J DiLeone; Kenner C Rice; F Gerard Moeller; Kathryn A Cunningham
Journal:  ACS Chem Neurosci       Date:  2015-07-07       Impact factor: 4.418

7.  Early stress prevents the potentiation of muscarinic excitation by calcium release in adult prefrontal cortex.

Authors:  Éliane Proulx; Deepika Suri; Scott P Heximer; Vidita A Vaidya; Evelyn K Lambe
Journal:  Biol Psychiatry       Date:  2013-10-28       Impact factor: 13.382

Review 8.  Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction.

Authors:  Kathryn A Cunningham; Noelle C Anastasio
Journal:  Neuropharmacology       Date:  2013-07-11       Impact factor: 5.250

9.  Chronic postnatal chemogenetic activation of forebrain excitatory neurons evokes persistent changes in mood behavior.

Authors:  Kamal Saba; Sonali S Salvi; Sthitapranjya Pati; Praachi Tiwari; Pratik R Chaudhari; Vijaya Verma; Sourish Mukhopadhyay; Darshana Kapri; Shital Suryavanshi; James P Clement; Anant B Patel; Vidita A Vaidya
Journal:  Elife       Date:  2020-09-21       Impact factor: 8.140

Review 10.  Monoamine-sensitive developmental periods impacting adult emotional and cognitive behaviors.

Authors:  Deepika Suri; Cátia M Teixeira; Martha K Caffrey Cagliostro; Darshini Mahadevia; Mark S Ansorge
Journal:  Neuropsychopharmacology       Date:  2014-09-02       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.